Vironova Medical AB is the investor of a novel chemical process technology for thionation of compounds used in pharmaceuticals and other areas. Thionating drug molecules can alter characteristics such as bioavailability and result in more potent and selective compounds. Our thionation reagent and process are available through out-licensing and partnership with Vironova Medical. In our drug discovery platform our thionation technology has been used to create novel compounds with improved characteristics.